PMID- 17545004
OWN - NLM
STAT- MEDLINE
DCOM- 20070626
LR  - 20171116
IS  - 1551-7136 (Print)
IS  - 1551-7136 (Linking)
VI  - 3
IP  - 1
DP  - 2007 Jan
TI  - Understanding the sensitized patient.
PG  - 1-9
AB  - New technologies have resulted in the ability to identify the presence of IgG 
      human leukocyte antigen (HLA) or non-HLA antibodies in the sera of potential 
      solid organ transplant recipients. Knowledge of the presence of these antibodies, 
      their antigen specificities, and strength (titer) is crucial to understanding a 
      patient's state of immunologic sensitization and reactivity. Finally, these data, 
      when correlated with sensitive crossmatch results, allow clinicians to make more 
      knowledgeable clinical decisions when paring donors and recipients for 
      transplant.
FAU - Kerman, Ronald H
AU  - Kerman RH
AD  - The University of Texas Medical School, Houston, TX 77030, USA. 
      ronald.h.kerman@uth.tmc.edu
LA  - eng
PT  - Journal Article
PT  - Review
PL  - United States
TA  - Heart Fail Clin
JT  - Heart failure clinics
JID - 101231934
SB  - IM
MH  - Antibody-Dependent Cell Cytotoxicity/immunology
MH  - Blood Grouping and Crossmatching
MH  - Contraindications
MH  - Cytotoxicity Tests, Immunologic
MH  - Enzyme-Linked Immunosorbent Assay
MH  - Flow Cytometry
MH  - Graft Rejection/diagnosis/immunology
MH  - Heart Transplantation/immunology
MH  - *Histocompatibility Testing
MH  - Humans
MH  - Lung Transplantation/immunology
MH  - Organ Transplantation
MH  - T-Lymphocytes/immunology
MH  - *Transplantation Immunology
RF  - 57
EDAT- 2007/06/05 09:00
MHDA- 2007/06/27 09:00
CRDT- 2007/06/05 09:00
PHST- 2007/06/05 09:00 [pubmed]
PHST- 2007/06/27 09:00 [medline]
PHST- 2007/06/05 09:00 [entrez]
AID - S1551-7136(07)00031-1 [pii]
AID - 10.1016/j.hfc.2007.03.003 [doi]
PST - ppublish
SO  - Heart Fail Clin. 2007 Jan;3(1):1-9. doi: 10.1016/j.hfc.2007.03.003.